Global & Disaster Medicine» Blog Archive » Clarithromycin and naproxen were dosed at 500 mg twice daily and 200 mg twice daily, respectively, along with oseltamivir and amoxicillin-clavulanate: The combination group achieved lower 30-day and 90-day mortality as well as shorter lengths of stay than the controls.

Clarithromycin and naproxen were dosed at 500 mg twice daily and 200 mg twice daily, respectively, along with oseltamivir and amoxicillin-clavulanate: The combination group achieved lower 30-day and 90-day mortality as well as shorter lengths of stay than the controls.

June 10th, 2017

Hung IFN, To KKW, Chan JFW, et al. Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection. Chest 2017;151:1069-1080.

“….Though limited by its single center, open-label status, this study nonetheless provides important proof-of-concept that antiviral therapy for hospitalized influenza patients can be supplemented with clarithromycin and naproxen to achieve better clinical outcomes…..”

This entry was posted on Saturday, June 10th, 2017 at 1:07 am and is filed under Influenza .
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Global & Disaster Medicine

Clarithromycin and naproxen were dosed at 500 mg twice daily and 200 mg twice daily, respectively, along with oseltamivir and amoxicillin-clavulanate: The combination group achieved lower 30-day and 90-day mortality as well as shorter lengths of stay than the controls.

Categories

Recent Posts

Archives

Admin